MANFORCE

More Indians fall head over heels for condom variants

Dotted, ribbed and ultra-thin designs help condom business hit five-year high, grow 13% by value last year compared with 7% in 2022.

Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothers

Introducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It took us 2-3 years to establish (ourselves). Though our medicines were half the price or even lower compared to our competitors, we were as effective. We were also earning - it's not that we were doing charity. We knew the secrets of the trade; there was no funny business. Once we succeeded, we were motivated, encouraged and there was no looking back," said Ramesh Juneja, chairman and wholetime director of Mankind Pharma.

Kartik Aaryan's brand empire: How the new superstar is ruling advertising world

Kartik Aaryan has emerged as a dominant force in both Bollywood and the advertising world, leveraging his successful film career and charismatic persona to become a sought-after brand ambassador. With a string of blockbuster films and a relatable on-screen presence, Aaryan's brand value has soared, attracting a diverse range of endorsements.

Fundamental Radar: Three factors may drive 14% domestic sales CAGR for Mankind Pharma

Mankind also has the most well-rounded therapeutic mix among peers, with strong brands across therapies. Its top-25 brands are still priced at a 21% discount to key competitors.

Fundamental Radar I Three factors seen driving 14% domestic sales CAGR for Mankind Pharma

Indian pharma market grows over 9 per cent in December

Among the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last month, according to data from research firm PharmaTrac. Antibiotic drug Augmentin and anti-diabetes Glycomet GP continued to be the top-selling medicine brands.

ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma's bottom-up journey to the leader board

The company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega News and Unwanted 72, Gas-o-Fast (antacid), AcneStar (skin brand) and multivitamin HealthOK News are among the top-selling consumer health brands in India. In May, Mankind had a successful IPO, listing at a 20% premium. The stock has since risen nearly 30%. Mankind had revenue of ₹8,749 crore and profit of ₹1,310 crore in FY23. Domestic revenue accounted for 97% of the total.

Local flavour: How condom marketers are making their bid

Some of their brand names are as colourful as their product range, but that’s not the only reason for the popularity of regional condom marketers.

Mankind Pharma IPO: Condom maker's Rs 4,326 crore IPO to hit the market next week

We continuously evolve and believe that every successful formula has an expiry date, says Mankind Pharma’s Rajeev Juneja

Mankind Pharma's IPO will open on April 25. Rajeev Juneja, VC & MD, shares the company's journey from starting with an initial capital of Rs 50 lakh to disrupting the market by cutting prices and bringing various combinations of healthcare products. Mankind Pharma's consumer brands include Manforce, PregaNews, Unwanted-72, Gas-O-Fast, and AcneStar, which are household names. Their distribution network is one of the largest in India and has grown substantially over the years.

300 drug formulations to have mandatory bar codes on packages soon to curb sales of spurious medicines

The decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity of the drug. The amendments to Drugs and Cosmetic Rules, 1945 which, once approved, will come into force from May next year.

Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drug

Under the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary license from Eli Lilly and Company. Mankind Pharma will be distributing the same, it added.

Mankind Pharma launches COVID protection policy to support families of deceased employees

Under the COVID Protection Policy, the company will contribute an amount equivalent to five years of the last drawn gross annual salary to the dependents of the deceased employee with a maximum limit of Rs 50 lakh, Mankind Pharma added.

Snapdeal clocks over 50% of its condom sale from Tier 3 cities

The company said in a press statement that its discreet shipping policy for sexual wellness products, access to variety and hesitation to purchase from an offline store, has been key drivers for growth in demand.

The curious case of two bananas: Ola, Policybazaar, Manforce Condoms cash in on the #RahulBoseMoment

Brands across social media brought their A-game to social media with most-witty marketing campaigns.

Mankind Pharma looking to sell 15 per cent stake; PE funds make a bee-line

Mankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.

Manforce withdraws controversial condom hoardings from Gujarat

The Confederation of All India Traders had raised an objection with the Centre earlier this week seeking ban on Manforce Condoms’s outdoor advertisements.

IPL: Delhi Daredevils expects FY17 to be a break-even year

Company has good support from advertisers, is building more fan engagement, says Hemant Dua, CEO at GMR Sports.

Sunny Leone insists she has moved on from porn: Why don't her critics get this?

There is a certain raciness to Leone that can never be separated from her, which is why campaigns like the Manforce ads are certainly on.

Mankind Pharma setting up Rs 100 crore facility in Rajasthan

The Delhi-based firm, which manufactures various over-the-counter products including condoms, said the new facility would produce bulk APIs.

Panel formed to rethink pricing of premium condoms

The Department of Pharmaceuticals has set up a panel to decide on the pricing of premium condoms after it fixed a cap of Rs6.50 a piece last year.

Premium condom market in India may collapse as drug pricing authority sets price cap of Rs 6.50

All men and women who like a bit of luxury where it counts may be forced to switch to economy class.Yes, a plain-vanilla, no-frills future awaits.

ASCI to use Facebook, Twitter to promote its online redressal service

The unique login ID and password for the online account provides consumers a single window to lodge complaints, fast-track complaints.